Investors who held FS KKR Capital Corp. stock between May 8, 2024, and February 25, 2026, are facing a legal deadline as a class action lawsuit moves forward. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the firm misled shareholders regarding its portfolio valuation.
More than 60 athletes have punched their tickets to the Games of the Future 2026 following five intense days of competition in Astana. The Phygital Contenders event saw over 200 participants from 20 countries push the boundaries of hybrid sport, blending digital precision with high-stakes physical performance in three distinct disciplines.
A class action lawsuit has been filed against Calix, Inc., accusing the telecommunications equipment provider of misleading shareholders about its financial health. The litigation centers on claims that the company inflated its first-quarter performance by masking the true impact of surging memory module costs.
Investors who purchased SES AI Corporation securities between January 29, 2025, and March 4, 2026, are being called to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the company misled the market through deceptive financial reporting and inflated partnership claims.
Investors who held shares in FS KKR Capital Corp. between May 8, 2024, and February 25, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding its portfolio valuation, restructuring effectiveness, and the long-term stability of its dividend program.
Investors who purchased Graphic Packaging Holding Company stock between February 4, 2025, and February 2, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding internal inventory struggles and weakening demand, leading to significant financial losses when the reality surfaced.
Investors who purchased POET Technologies stock between April 1 and April 27, 2026, face potential financial losses following a class action lawsuit filed by the Schall Law Firm. The legal action alleges that the company violated federal securities laws by misrepresenting its tax status and internal business conduct.
Investors who purchased Immutep Limited shares between March 24, 2025, and March 12, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the efficacy of its TACTI-004 clinical trial for the drug eftilagimod alfa.
Investors who purchased POET Technologies shares between April 1 and April 27, 2026, face a critical window to join a class action lawsuit. The DJS Law Group is currently organizing plaintiffs to address allegations that the company misled the market regarding its tax status as a passive foreign investment entity.
Investors who purchased Commvault Systems stock between April 29, 2025, and January 26, 2026, are being urged to join a class action lawsuit against the company. The Schall Law Firm alleges that Commvault misled the market regarding its annual recurring revenue growth during that period, causing significant financial losses.
Investors who purchased Immutep Limited securities between March 24, 2025, and March 12, 2026, face a critical window to join a class action lawsuit against the company. The Schall Law Firm is spearheading the litigation, alleging that the biotech firm misled shareholders regarding the results of its TACTI-004 clinical trial.
Investors who purchased Graphic Packaging Holding Company stock between February 4, 2025, and February 2, 2026, are facing a legal deadline of July 6, 2026, to join a class action lawsuit alleging the firm misled the market regarding inventory management, operational costs, and declining consumer demand.
Investors who purchased Globant S.A. shares between February 15, 2024, and August 14, 2025, face a June 23, 2026, deadline to join a class action lawsuit. The litigation alleges the company misled the market regarding the actual success of its strategic Latin American pivot.
Shareholders who acquired Globant S.A. securities between February 15, 2024, and August 14, 2025, face a critical deadline to join a class action lawsuit. The Schall Law Firm is currently organizing the case, alleging that the technology company misled the market regarding its strategic performance and internal stability during this period.
A federal class action lawsuit now targets SES AI Corporation, alleging the battery technology developer artificially inflated its financial standing. The complaint centers on claims that the company disguised service payments as revenue, misleading shareholders regarding the true performance of its Molecular Universe platform throughout early 2025 and 2026.
The Board of Directors at Sivers Semiconductors AB abruptly pulled three key items from its 2026 Annual General Meeting agenda today. The decision, announced in Kista, Sweden, halts immediate voting on proposed employee incentive programs to ensure the incoming board has a direct role in shaping the company's compensation strategy.
Shenzhen-based fitness technology firm Speediance has signed a deal to become the official smart equipment partner of the ATHX competition series through December 2027. The agreement places the company’s portable Gym Nano resistance system at the center of athlete warm-up and recovery zones across 57 international events.
Lundbeck’s investigational antibody asedebart has shown promise in treating Cushing’s disease, with early Phase II trial results indicating successful normalization of urinary free cortisol levels in the vast majority of evaluable patients, according to data presented at the 2026 Endocrine Society’s Annual Meeting in Chicago.
A thousand-euro drone crippling a multi-million-euro asset has become the new baseline for modern combat. As Eurosatory 2026 opens in Paris, tech firm Sopra Steria argues that military superiority no longer rests on platform power, but on the relentless speed of data processing and the ability to absorb saturation.
With the acquisition of a controlling interest in Genesis Digital Assets, Euronext Amsterdam-listed SWI Group is aggressively expanding its footprint into the United States. The deal adds 1.3 GW of energized capacity to the firm’s portfolio, positioning the conglomerate as a major player in the global AI and high-performance computing race.
With a $500 million acquisition of a significant stake in Genesis Digital Assets, SWI Group is pivoting a massive 1.3 GW American portfolio away from cryptocurrency mining. The move signals a strategic shift toward high-performance computing, positioning the firm to command a transatlantic footprint of 3.6 GW for AI workloads.
With the acquisition of a majority stake in Genesis Digital Assets, the London and Amsterdam-based SWI Group is aggressively expanding its footprint into the United States. This move secures 1.3 gigawatts of energized grid capacity, positioning the conglomerate to pivot toward high-performance computing and heavy AI-driven workloads.
Munich's Intersolar Europe exhibition will host ZTT from June 23–25, 2026, as the company prepares to demonstrate its end-to-end capabilities in the renewable sector. Operating from booth C3.480, the firm plans to highlight its expanded ecosystem of solar, energy storage, and hydrogen technologies designed for global grid modernization.
A drone costing a few thousand euros now routinely neutralizes equipment worth millions, forcing European military planners to abandon the pursuit of expensive platforms in favor of speed and data. As Eurosatory 2026 opens, Sopra Steria’s latest trend book argues that strategic autonomy has shifted from a distant ambition to an immediate necessity.
London-based SWI Group has secured a significant stake in Genesis Digital Assets Limited for $500 million, pivoting 1.3 gigawatts of American power infrastructure away from cryptocurrency mining toward high-performance computing and artificial intelligence, a move that pushes the firm’s total transatlantic capacity to 3.6 gigawatts.
Seven out of eight evaluable patients achieved normalized cortisol levels during a Phase II trial of asedebart, a novel monoclonal antibody targeting adrenocorticotropic hormone. The findings, presented at the Endocrine Society's annual meeting in Chicago, offer a potential new therapeutic path for treating the underlying causes of Cushing's disease.
As soccer season kicks off globally, oxygen therapy patients are finding that careful logistics and modern portable technology allow them to transition from home watch parties to live stadium environments without compromising their health or missing the excitement of the match.
Modern combat demands more than raw processing power; it requires rugged intelligence capable of surviving the front lines. At EUROSATORY 2026 in Paris, SINTRONES Technology Corp. is unveiling new tactical edge computing platforms designed to bring real-time AI inference and mission-critical data security directly into the field.
In the skies above Segovia, a new collaborative strike capability is taking shape as the Destinus Hornet interceptor successfully integrated Shield AI’s Hivemind software. The flight exercise represents a critical leap in neutralizing drone swarms and loitering munitions through autonomous coordination in contested airspace.
With 91% of executives linking electrification to national energy security, a new 18-country survey reveals that geopolitical volatility is forcing businesses to abandon fossil fuels. Leaders are no longer viewing the transition as a green initiative, but as a critical hedge against global instability and supply chain disruption.
